$HGEN lenzilumab doubled the risk of cardiac arrest and development of pulmonary embolisms in their ph3 covid trial. no wonder the FDA denied EUA.
5
1
@tomengine Let's call bullshit when you see it. Your comment is bullshit. There is no statistical difference in the rate of overall AEs or individual AEs. Thanks for playing.